Cancer GENETICS AND EPIGENETICS
癌症遗传学和表观遗传学
基本信息
- 批准号:8512116
- 负责人:
- 金额:$ 3.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAreaAutomobile DrivingBasic ScienceBioinformaticsBiometryBrainBreastCancer Center Support GrantCellsChromatinChromosomal InstabilityClassificationClinicalCollaborationsDNADNA DamageDNA RepairDNA SequenceDefectDetectionDevelopmentDiagnosisDirect CostsDisease OutcomeDoctor of PhilosophyEpigenetic ProcessFailureFunctional RNAFundingGene Expression RegulationGenesGeneticGenomeGenomic InstabilityGenomicsGenomics Shared ResourceGoalsGrantHumanIndividualInstitutesInstructionInvestigationJournalsLungMalignant NeoplasmsMethylationMicroRNAsMolecularMolecular Classification of TumorsMutationNormal CellNucleotidesOutcomeOxidative StressPathway interactionsPatientsPatternPeer ReviewPhenotypePositioning AttributePreventionProgram DevelopmentProstatePublic Health SchoolsPublicationsPublishingResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsSchoolsScreening procedureSourceSystemTherapeuticTherapeutic InterventionTranslatingTranslationsUniversitiesVariantanticancer researchcancer carecancer cellcancer geneticscancer genomecancer genomicscancer initiationcancer therapycollegeenvironmental radiationgene functiongenetic analysisgenome-widehistone modificationimprovedmedical schoolsmembermortalitynovelnovel strategiesoutcome forecastprognosticprogramsradiation carcinogenradiation carcinogenesisrepairedresponsesmall moleculetranslational studytumortumor progressiontumorigenesis
项目摘要
PROJECT SUMMARY:
The goal of the Cancer Genetics and Epigenetics (CGE) Program is to better understand the fundamental mechanisms underlying genetic and epigenetic instability and its contribution to the initiation and progression of human tumors. In pursuit of this goal, the program organizes its research efforts into three areas of focus: 1) DNA damage and repair and genome instability; 2) epigenetics and gene regulation; and 3) cancer genetics /genomics.
The CGE Program consists of 29 core members from 13 academic departments and three schools across Emory University, including the School of Medicine, the School of Public Health and Emory College. CGE Program members currently have $15,110,592 in research grant funding (annual direct costs), of which $12,849,105 is peer-reviewed and $4,277,290 (34%) is NCI-funded. Program members have published 227 cancer-related publications in the cun-ent project period. Among these, 12% and 25% represent intra- and inter-programmafic and interactions, respectively.
In the current project period, discovery efforts have led to the identification of key genes whose mutation or altered expression contribute to cancer initiation and progression. Basic discoveries in the area of cancer epigenetics have prompted early small molecule screening efforts to identify novel targeted agents.
Program development and key recruitments have strengthened and enhanced intra-programmatic activities in the areas of human radiation carcinogenesis, DNA damage/repair, and cancer genomics. This has been leveraged into several new multi-investigator grants and has provided key translational avenues for the program through increased inter-programmatic activities and cross-cutting genomics initiatives. Successful genomic studies resulted in the molecular classification of tumors and the identification of genes, gene
signatures, and clinical factors with prognostic value in prostate, breast, brain, and lung malignancies. The Cancer Genetics and Epigenetics Program facilitates scientific collaborations and cancer research discoveries and has positioned itself for continued development in the forthcoming project period.
项目摘要:
癌症遗传学和表观遗传学(CGE)计划的目标是更好地了解遗传和表观遗传不稳定性的基本机制及其对人肿瘤起始和进展的贡献。为了实现这一目标,该计划将其研究工作组织为三个重点领域:1)DNA损害和修复以及基因组不稳定性; 2)表观遗传学和基因调节; 3)癌症遗传学 /基因组学。
CGE计划由来自13个学术系和埃默里大学(Emory University)的3所学校的29名核心成员组成,包括医学院,公共卫生学院和埃默里学院。 CGE计划成员目前拥有15,110,592美元的研究赠款资金(年度直接费用),其中12,849,105美元是同行评审,4,277,290美元(34%)是NCI资助的。计划成员在CUN-ENT项目期间发表了227个与癌症相关的出版物。其中,有12%和25%分别代表了跨间隙和相互作用。
在当前的项目时期,发现工作导致了关键基因的鉴定,其突变或表达改变会导致癌症的启动和进展。癌症表观遗传学领域的基本发现促使早期的小分子筛查工作以鉴定新的靶向剂。
计划的开发和关键募集已加强并增强了人类辐射致癌,DNA损伤/修复和癌症基因组学领域的概括性活动。这已被利用为几个新的多侵略器补助金,并通过增加程序间活动和跨记录基因组学计划为该计划提供了关键的转化途径。成功的基因组研究导致肿瘤的分子分类和基因的鉴定。
前列腺,乳房,大脑和肺部恶性肿瘤的特征和临床因素。癌症遗传学和表观遗传学计划促进了科学合作和癌症研究发现,并在即将到来的项目时期定位了持续发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paula M. Vertino其他文献
Paula M. Vertino的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paula M. Vertino', 18)}}的其他基金
Relaxed Polymerase Pausing as a Driver of Epigenetic Plasticity and Cancer Cell Invasion
松弛的聚合酶暂停是表观遗传可塑性和癌细胞侵袭的驱动因素
- 批准号:
10600087 - 财政年份:2021
- 资助金额:
$ 3.02万 - 项目类别:
Relaxed Polymerase Pausing as a Driver of Epigenetic Plasticity and Cancer Cell Invasion
松弛的聚合酶暂停是表观遗传可塑性和癌细胞侵袭的驱动因素
- 批准号:
10747536 - 财政年份:2021
- 资助金额:
$ 3.02万 - 项目类别:
Relaxed Polymerase Pausing as a Driver of Epigenetic Plasticity and Cancer Cell Invasion
松弛的聚合酶暂停是表观遗传可塑性和癌细胞侵袭的驱动因素
- 批准号:
10378710 - 财政年份:2021
- 资助金额:
$ 3.02万 - 项目类别:
2010 FASEB Conference "Biological Methylation:From DNA to Histones and Beyond"
2010年FASEB会议“生物甲基化:从DNA到组蛋白及其他”
- 批准号:
7911239 - 财政年份:2010
- 资助金额:
$ 3.02万 - 项目类别:
Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers
定义人类癌症中异常 DNA 甲基化的基因组特征
- 批准号:
8246510 - 财政年份:2009
- 资助金额:
$ 3.02万 - 项目类别:
Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers
定义人类癌症中异常 DNA 甲基化的基因组特征
- 批准号:
7742918 - 财政年份:2009
- 资助金额:
$ 3.02万 - 项目类别:
Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers
定义人类癌症中异常 DNA 甲基化的基因组特征
- 批准号:
8069622 - 财政年份:2009
- 资助金额:
$ 3.02万 - 项目类别:
Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers
定义人类癌症中异常 DNA 甲基化的基因组特征
- 批准号:
7843531 - 财政年份:2009
- 资助金额:
$ 3.02万 - 项目类别:
Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers
定义人类癌症中异常 DNA 甲基化的基因组特征
- 批准号:
8459567 - 财政年份:2009
- 资助金额:
$ 3.02万 - 项目类别:
GENESIS AND CONSEQUENCES OF ABERRANT DNA METHYLATION
异常 DNA 甲基化的起源和后果
- 批准号:
6164264 - 财政年份:1998
- 资助金额:
$ 3.02万 - 项目类别:
相似国自然基金
跨区域调水工程与区域经济增长:效应测度、机制探究与政策建议
- 批准号:72373114
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
农产品区域公用品牌地方政府干预机制与政策优化研究
- 批准号:72373068
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
新型城镇化与区域协调发展的机制与治理体系研究
- 批准号:72334006
- 批准年份:2023
- 资助金额:167 万元
- 项目类别:重点项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
多时序CT联合多区域数字病理早期预测胃癌新辅助化疗抵抗的研究
- 批准号:82360345
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Circadian and mitochondrial dysfunction in alcohol-related liver disease
酒精相关性肝病中的昼夜节律和线粒体功能障碍
- 批准号:
10667861 - 财政年份:2023
- 资助金额:
$ 3.02万 - 项目类别:
Investigating the role of public transit on health behaviors among older adults with disabilities
调查公共交通对残疾老年人健康行为的作用
- 批准号:
10644067 - 财政年份:2023
- 资助金额:
$ 3.02万 - 项目类别:
Influence of Particulate Matter on Fetal Mitochondrial Programming
颗粒物对胎儿线粒体编程的影响
- 批准号:
10734403 - 财政年份:2023
- 资助金额:
$ 3.02万 - 项目类别: